Literature DB >> 5420607

Insulin secretion in heart failure.

B Sharma, P A Majid, B C Pakrashi, J R Dykes, S H Taylor.   

Abstract

Insulin secretion tests were carried out before and after treatment in patients with severe congestive heart failure. Before treatment the plasma insulin level and the insulin secretion response to intravenous tolbutamide were significantly reduced in all patients. In patients who made a good clinical recovery the plasma insulin level and the insulin secretion response were significantly improved. Patients who had a poor response to medical treatment showed little improvement in their insulin secretion test. This suppression of insulin secretion is probably due to the reduced blood flow to the pancreas together with a high level of circulating catecholamines.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5420607      PMCID： PMC1700297          DOI： 10.1136/bmj.2.5706.396

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  8 in total

1.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE.

Authors:  C A CHIDSEY; E BRAUNWALD; A G MORROW
Journal:  Am J Med       Date:  1965-09       Impact factor: 4.965

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  Observations on an enzymic method for the estimation of pyruvate in blood.

Authors:  J A GLOSTER; P HARRIS
Journal:  Clin Chim Acta       Date:  1962-03       Impact factor: 3.786

4.  Inhibition of insulin secretion by infused epinephrine in rhesus monkeys.

Authors:  A O Kris; R E Miller; F E Wherry; J W Mason
Journal:  Endocrinology       Date:  1966-01       Impact factor: 4.736

5.  Glucose metabolism and plasma insulin level during epinephrine infusion in the dog.

Authors:  N Altszuler; R Steele; I Rathgeb; R C De Bodo
Journal:  Am J Physiol       Date:  1967-03

6.  Effect of selected hexoses, of epinephrine and of glucagon on insulin secretion in man.

Authors:  J H Karam; S G Grasso; L C Wegienka; G M Grodsky; P H Forsham
Journal:  Diabetes       Date:  1966-08       Impact factor: 9.461

7.  The effect of epinephrine on immunoreactive insulin levels in man.

Authors:  D Porte; A L Graber; T Kuzuya; R H Williams
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

8.  Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.

Authors:  E P Marbach; M H Weil
Journal:  Clin Chem       Date:  1967-04       Impact factor: 8.327
  8 in total
  5 in total

1.  Autonomic control of insulin secretion and the treatment of heart failure.

Authors:  P A Majid; C Saxton; J R Dykes; M C Galvin; S H Taylor
Journal:  Br Med J       Date:  1970-11-07

Review 2.  Insulin and heart failure.

Authors:  S H Taylor
Journal:  Br Heart J       Date:  1971-05

3.  Plasma insulin in heart disease.

Authors:  S H Taylor; P A Majid; J R Dykes; B Sharma; C Saxton
Journal:  Proc R Soc Med       Date:  1971-05

4.  Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats.

Authors:  Vojtech Melenovsky; Jan Benes; Petra Skaroupkova; David Sedmera; Hynek Strnad; Michal Kolar; Cestmir Vlcek; Jiri Petrak; Jiri Benes; Frantisek Papousek; Olena Oliyarnyk; Ludmila Kazdova; Ludek Cervenka
Journal:  Mol Cell Biochem       Date:  2011-04-05       Impact factor: 3.396

5.  Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure.

Authors:  Vojtech Melenovsky; Jan Benes; Janka Franekova; Jan Kovar; Barry A Borlaug; Marketa Segetova; Andrea Tura; Tereza Pelikanova
Journal:  J Am Heart Assoc       Date:  2017-08-07       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.